Story perspectives
Study Finds Eating Habits Impact Diabetes Treatment Success
9/19/2025
43 9
1 of 1
Story summary
- A Japanese study revealed that eating behaviors influence responses to GLP-1 receptor agonist (RA) therapy in type 2 diabetes (T2D) patients.
- Patients on liraglutide, dulaglutide, or semaglutide experienced notable reductions in HbA1c, body weight, and body fat.
- External eating linked to better treatment outcomes, while emotional eating hindered weight loss.
- The study involved 92 adults over 12 months, highlighting the need for behavioral assessments in future research.
